Rigel Pharmaceuticals Cash from Investing Quarterly:
-108.29M for Dec. 31, 2012Rigel Pharmaceuticals Historical Cash from Investing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -108.29M |
| Sept. 30, 2012 | 19.08M |
| June 30, 2012 | 23.97M |
| March 31, 2012 | 26.18M |
| Dec. 31, 2011 | 17.84M |
| Sept. 30, 2011 | -11.50M |
| June 30, 2011 | -106.98M |
| March 31, 2011 | 37.79M |
| Dec. 31, 2010 | -23.96M |
| Sept. 30, 2010 | 8.871M |
| June 30, 2010 | -62.32M |
| March 31, 2010 | 24.00M |
| Dec. 31, 2009 | -57.33M |
| Sept. 30, 2009 | -5.019M |
| June 30, 2009 | 11.56M |
| March 31, 2009 | 20.12M |
| Dec. 31, 2008 | 13.85M |
| Sept. 30, 2008 | 32.74M |
| June 30, 2008 | -30.33M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
About Cash From Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
RIGL Cash from Investing Quarterly Benchmarks
| Companies | |
|---|---|
| AstraZeneca | -364.00M |
| MEI Pharma | -0.002M |
| Lannett Company | -5.038M |
RIGL Cash from Investing Quarterly Rankings
| Overall |
51st percentile 3898 of 8002 |
| Sector |
24th percentile 517 of 684 in Healthcare |
| Industry |
25th percentile 51 of 68 in Drug Manufacturers - Specialty & Generic |
RIGL Cash from Investing Quarterly Range, Past 5 Years
| Minimum | -108.29M | Dec 2012 |
| Maximum | 37.79M | Mar 2011 |
| Average | -8.932M |
